01 8Bayer Inc.
01 12315715
02 12526636
03 12532865
04 12549558
05 12578438
06 12666170
07 12675980
08 12796238
01 8Regorafenib
01 8Tablet
01 12018-12-22
02 12020-01-12
03 12024-05-19
04 12024-07-22
05 12025-08-29
06 12027-09-29
07 12028-01-18
08 12031-04-08
Patent Expiration Date : 2024-07-22
Date Granted : 2013-08-06
Brand Name : STIVARGA
Patent Number : 2532865
Filing Date : 2004-07-22
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-07-22
Date Granted : 2013-08-06
Patent Expiration Date : 2024-05-19
Date Granted : 2012-10-02
Brand Name : STIVARGA
Patent Number : 2526636
Filing Date : 2004-05-19
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-05-19
Date Granted : 2012-10-02
Patent Expiration Date : 2018-12-22
Date Granted : 2010-06-22
Brand Name : STIVARGA
Patent Number : 2315715
Filing Date : 1998-12-22
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2010-06-22
Patent Expiration Date : 2020-01-12
Date Granted : 2010-08-31
Brand Name : STIVARGA
Patent Number : 2549558
Filing Date : 2000-01-12
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-01-12
Date Granted : 2010-08-31
Patent Expiration Date : 2025-08-29
Date Granted : 2015-10-06
Brand Name : STIVARGA
Patent Number : 2578438
Filing Date : 2005-08-29
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-08-29
Date Granted : 2015-10-06
Patent Expiration Date : 2027-09-29
Date Granted : 2016-05-24
Brand Name : STIVARGA
Patent Number : 2666170
Filing Date : 2007-09-29
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-09-29
Date Granted : 2016-05-24
Patent Expiration Date : 2028-01-18
Date Granted : 2016-06-21
Brand Name : STIVARGA
Patent Number : 2675980
Filing Date : 2008-01-18
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-01-18
Date Granted : 2016-06-21
Patent Expiration Date : 2031-04-08
Date Granted : 2019-12-31
Brand Name : STIVARGA
Patent Number : 2796238
Filing Date : 2011-04-08
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2031-04-08
Date Granted : 2019-12-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
